# Amprius Technologies (AMPX) investment thesis

By Clearthesis. Data as of November 12, 2026. Written November 12, 2026. Full page: https://www.clearthesis.ai/thesis/AMPX?utm_source=ai_agent&utm_medium=markdown

Amprius Technologies is an advanced battery maker that uses silicon nanowires to build the most energy-dense cells in the world for military drones and high-altitude aircraft.

The question investors are asking: Amprius' stock has risen sharply as its revenue nearly doubled this year. Can it keep winning high-margin defense contracts, or has the valuation already peaked?

## Summary

Amprius is a hypergrowth battery developer that is successfully scaling its high-performance silicon-anode cells through an asset-light manufacturing model. The primary constraint is the unproven ability to reach 12 million cells in annual capacity while maintaining high yields.

## The thesis in brief

- Amprius Technologies is an advanced battery manufacturer that builds high-energy density cells using proprietary silicon nanowire anodes, a technology that allowed it to reach $0.1 billion in revenue last year while growing 202.1%. The business is currently transitioning from a pilot-scale research lab into a commercial-scale producer for the defense and aerospace industries.
- The company is successfully decoupling its growth from heavy factory construction by shifting to an asset-light contract manufacturing model, which allows it to scale production 82.7% in the latest quarter without the multi-billion dollar capital costs typical of battery competitors. This pivot drove GAAP gross margins to 27% in Q3 2026, proving that proprietary cell design can be profitable even when outsourced to manufacturing partners.
- The next phase of value creation hinges on domestic production capacity mandated by a $75 million contract from the U.S. Department of War, which requires Amprius to deliver 12 million cells annually by 2028. This contract provides a massive multi-year revenue floor and acts as a regulatory barrier against foreign competitors who cannot meet domestic manufacturing requirements for sensitive defense platforms.
- The primary risk is the unproven execution of high-volume production for second-generation cells at the scale required for global automotive contracts, as the company has not yet secured a flagship high-performance electric vehicle deal. We lean positive on the business because it has demonstrated a rare ability to expand margins while doubling revenue, all while securing non-dilutive government funding.

- Amprius Technologies manufactures silicon-anode batteries with twice the energy density of conventional cells.
- The growth driver is a $75 million defense contract that establishes the company as a domestic supplier.
- It is successfully pivoting to an asset-light manufacturing model to reach profitability faster.
- We lean positive: the business is doubling revenue while expanding gross margins to 27%.

## The business

- Stage: Hypergrowth

What does it do? Amprius Technologies is a hypergrowth business that earns money by designing and selling ultra-high-performance lithium-ion battery cells to customers who value weight and energy density above all else. The company earns revenue by selling individual battery cells and complete battery packs to developers of drones, high-altitude stratospheric platforms, and autonomous underwater vehicles. Unlike commodity battery makers, Amprius charges a premium for its silicon nanowire technology, which provides roughly double the energy density and flight time of standard batteries. Customers pay for these cells to enable missions that were previously impossible, such as multi-day solar-powered flights or heavy-lift logistics drones.

Where does revenue come from? The vast majority of revenue is generated from the sale of silicon-anode battery cells to aerospace and defense customers. Silicon nanowire cells represent the core product line, though the company also provides specialized battery engineering services. A rapidly growing portion of revenue is tied to domestic defense contracts, which now include initial obligations from a $75 million government award focused on securing American battery supply chains.

Who are its customers? Amprius Technologies serves a concentrated base of high-end aerospace, defense, and advanced mobility clients, including leading drone developers like Quantum Systems. In the latest quarter, the company reported $12.2 million in U.S. revenue, a 2.3x increase compared to the prior period, driven by expanded shipments for military unmanned systems and stratospheric aerospace platforms. While the company does not disclose a total user count, its growth is tied to design wins with global leaders in maritime and defense technology for autonomous underwater vehicles and solar-powered aircraft. The customer profile is shifting toward large-scale government obligations, highlighted by a $22.3 million initial obligation from the U.S. Department of War.

What gives it staying power? Amprius possesses staying power through a deep library of intellectual property around silicon nanowires and the recent regulatory advantage of NDAA compliance. High switching costs exist for defense platforms that are engineered around the specific dimensions and energy density of Amprius cells.

Where is it headed? The company is making a major strategic bet on a "fabless" manufacturing strategy that relies on contract manufacturing partners rather than building owned gigafactories. By outsourcing production to partners like Caminus, management aims to scale to 12 million cells per year by 2028. If successful, this model will allow Amprius to maintain high margins while avoiding the massive dilution typical of capital-intensive battery startups.

## Financial performance

Revenue is in a state of hypergrowth as Amprius successfully converts its technical lead into commercial sales, with revenue rising 82.7% in the latest quarter. This growth is accelerating as the company moves into higher-volume production for aerospace customers, supported by a guidance raise to $145 million for the full year 2026.

Cash generation is currently negative as the company invests in inventory and domestic production capability, though the narrowing net loss of $3.5 million suggests the business is approaching a profitable scale. Free cash flow margin remains at -48.7%, but the shift to contract manufacturing has significantly reduced the capital expenditure required to grow, with full-year capital spending expected to remain under $10 million.

The balance sheet is exceptionally lean for a battery manufacturer, carrying just $6.4 million in debt against $60.7 million in cash. While cash has declined from $90.5 million at the start of the year, the company recently secured a $75 million non-dilutive government award and completed a warrant exchange that strengthened the equity base.

Amprius is an emerging financial leader in the battery sector that has proven it can double its revenue while expanding gross margins to 27%.

- Dividend note: Amprius Technologies does not pay a dividend and uses all available cash to fund the scaling of its high-energy density battery production. This is typical for a hypergrowth technology company in the battery sector, where capital is better used for manufacturing expansion than for income payments. The company has not engaged in a share buyback program, and the share count has risen significantly over the past year as it used stock to fund operations and employee incentives. An owner's slice of the business has shrunk as the share count increased from 134.5 million to 146.6 million in the last nine months, a move intended to preserve cash for growth.

- Last quarter note: Q3 FY2026 revenue was $39.1 million, an 82.7% increase year-over-year, while EPS was -$0.02. This result signals that the business is accelerating toward profitability, as gross margins expanded to 27% and the net loss narrowed sequentially.

What's working well? The transition to contract manufacturing is delivering immediate margin expansion, with GAAP gross profit rising 217% year-over-year. This strategy allows the company to reach $39.1 million in quarterly revenue without building expensive factories, proving the silicon nanowire IP is the true value driver.

What to watch? The primary concern is the conversion of the $75 million defense contract into operational capacity, specifically the goal of 12 million cells annually by 2028. If the company fails to meet the technical milestones required to unlock the full $75 million, it may face a liquidity gap that requires a dilutive capital raise.

## Moat and competition

- Moat: Narrow
- Moat why: Revenue is highly concentrated in a few aerospace customers and the company has not yet proven it can scale production to 12 million cells annually.
- Moat direction: Strengthening. Secured a $75 million Department of War contract that mandates NDAA-compliant domestic production, creating a regulatory barrier for foreign rivals.
- Industry stage: Growth
- Industry growth estimate: ~20% annually
- Competitors: Enovix. ENVX. Competing silicon-anode battery developer with internal manufacturing facilities focused on consumer electronics and wearables.,QuantumScape. QS. Developing solid-state batteries with massive OEM backing, primarily targeting the mass-market automotive sector.,CATL. World's largest battery manufacturer using scale to dominate commodity EV markets with lower-cost graphite-based chemistries.,Sila Nanotechnologies. Private competitor providing silicon-composite materials for battery anodes, recently securing supply deals with premium automotive brands.
- Moat sources: Brand & IP. present, Regulatory Moat. partial, Switching Costs. partial, Efficient Scale
- Moat evidence: Gross margin: 27% Q3 FY2026, Revenue: 202% FY2025 growth, Defense Backlog: $75M contract win

### Industry
The advanced lithium-ion battery market is currently worth approximately $95 billion and is growing at 5.3% annually, though the high-energy density segment for aerospace is expanding much faster. The industry is shaped by a intense drive for energy density and domestic supply chain security, which allows specialized players to hold high prices while commodity makers face a race to the bottom. Amprius stands as a niche technology leader in this market, currently focusing on high-margin defense and aerospace applications where its energy density is essential for mission success.

### Competition
The high-performance battery market is intensely competitive as startups race to prove that new chemistries can be manufactured at a scale and cost that rival the established players. Barriers to entry are high due to the immense technical complexity of silicon anodes, but the long-term pricing power of developers depends on their ability to secure exclusive design wins.

Enovix is the most direct competitor, also using silicon anodes but choosing to build its own manufacturing lines in Malaysia to target consumer electronics. QuantumScape represents a different technical path with solid-state batteries, enjoying far larger capital resources and deep partnerships with major automotive manufacturers like Volkswagen. CATL and other global leaders threaten the industry by potentially commoditizing silicon-composite materials once the technology matures.

Amprius is currently gaining share in the high-end drone and stratospheric aviation markets, as evidenced by its 83% revenue growth and new $75 million defense contract.

### Moat
The primary source of protection for Amprius is its Brand and IP, specifically its 100% silicon nanowire anode architecture which allows for energy densities that graphite-based competitors cannot replicate. This technology is protected by a deep patent portfolio and specialized manufacturing knowledge that creates high switching costs for aerospace customers. A stratospheric platform designed around the weight and density of Amprius cells cannot easily switch to a heavier competitor without redesigning the entire aircraft.

The current financial numbers, including a 27% gross margin and an 83% growth rate, collectively prove that the technical lead is translating into pricing power. These margins are significantly higher than those of typical battery startups, suggesting that customers are willing to pay a premium for the performance edge. The competitive advantage is capped at narrow because silicon is a common material and a better-funded rival could eventually develop a silicon-composite anode that offers similar performance at a lower price point.

The moat is strengthening as the company locks in long-term government contracts that require domestic, NDAA-compliant manufacturing. This regulatory barrier makes it extremely difficult for foreign competitors to displace Amprius in the high-growth U.S. defense sector, regardless of their manufacturing scale.

## Management

- CEO: Thomas Michael Stepien
- Management rating: Strong
- Execution: High
- Execution evidence: Raised 2026 revenue guidance to $145M and expanded gross margins to 27% ahead of targets.
- Capital allocation: Disciplined
- Capital allocation evidence: Successfully pivoted to asset-light contract manufacturing, keeping CapEx under $10M while doubling revenue.
- Alignment: Mixed
- Alignment evidence: CEO holds a significant stake, but share count rose 9% in nine months due to stock-based compensation.
- Management decision: Shifting to a contract manufacturing model with Caminus to scale production without dilutive capital raises for factories.
- Management decision: Securing a $75 million Department of War contract to establish domestic NDAA-compliant battery production in the U.S.
- Management decision: Completing a warrant-for-share exchange to simplify the capital structure and reduce potential future dilution.

Management has demonstrated exceptional strategic judgment by pivoting to a contract manufacturing model that delivers 27% gross margins without requiring billions in factory construction. Tom Stepien has successfully moved the company past the research phase, delivering four consecutive quarters of high revenue growth and narrowing the net loss to just $3.5 million. The ability to secure $75 million in non-dilutive government funding while maintaining a lean $6.4 million debt load suggests a highly disciplined approach to capital that prioritizes shareholder value over reckless expansion.

The primary governance risk is the high level of dependence on the technical vision of the leadership team, including founder Kang Sun who now serves as an executive advisor. While Tom Stepien is a proven operator, the loss of key technical personnel could damage the proprietary silicon nanowire roadmap that sustains the moat. There is no dual-class share structure, but the company’s small board and concentrated institutional ownership mean individual shareholders have limited influence over the aggressive shift toward defense markets.

## Quality scorecard

Each business is scored 1 to 5 on what makes a company worth owning for the long term.

- Moat strength: 3 out of 5. Proprietary silicon nanowire IP delivers high density, but revenue concentration and unproven scale limit it.
- Capital efficiency: 4 out of 5. Shift to contract manufacturing allows 83% growth while keeping capital expenditures under $10 million.
- Revenue growth: 5 out of 5. Revenue grew 82.7% in the latest quarter and management raised full-year 2026 guidance.
- Growth runway: 4 out of 5. The $75 million defense contract and aerospace demand for 500 Wh/kg cells offer massive expansion room.
- Management: 5 out of 5. Tom Stepien successfully raised guidance while expanding margins and securing $75 million in non-dilutive funding.
- AI resilience: 3 out of 5. Advanced battery technology is neutral to AI disruption, though AI-powered drones represent a significant demand source.
- Risk resilience: 4 out of 5. Successfully managed the pivot from pilot production to commercial scale while narrowing losses to $3.5 million.

## Key numbers (as of November 12, 2026)

- Revenue over the last twelve months: $0.1 billion
- Revenue growth from a year earlier: 202.1%
- Average yearly revenue growth over five years: 126.5%
- Gross margin: 24.8%
- Operating margin: -63.9%
- Free cash flow margin: -48.7%
- Return on invested capital: -14.2%

## Fair value and verdict

Clearthesis also estimates Amprius Technologies's fair value, models what the stock could be worth over the next five years, and gives a verdict (whether it looks like a buy at today's price). Those are on the full thesis: https://www.clearthesis.ai/thesis/AMPX?utm_source=ai_agent&utm_medium=markdown

Latest news and what it means for the thesis: https://www.clearthesis.ai/updates/AMPX?utm_source=ai_agent&utm_medium=markdown

## Sources

- [SEC 10-K Annual Report](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=AMPX&type=10-K&dateb=&owner=include&count=5), November 12, 2026
- [SEC 10-Q Quarterly Report](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=AMPX&type=10-Q&dateb=&owner=include&count=5), November 12, 2026
- [Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent Business Highlights :: Amprius Technologies, Inc. (AMPX)](https://ir.amprius.com/news-events/press-releases/detail/177/amprius-technologies-reports-third-quarter-2026-financial-results-and-recent-business-highlights), November 12, 2026
- [Amprius Technologies Reports First Quarter 2026 Financial Results and Recent Business Highlights :: Amprius Technologies, Inc. (AMPX)](https://ir.amprius.com/news-events/press-releases/detail/165/amprius-technologies-reports-first-quarter-2026-financial-results-and-recent-business-highlights), November 12, 2026
- [Earnings Press Release (2026-11-10)](https://www.sec.gov/Archives/edgar/data/1899287/000189928726000069/ampx-2026x11x03x8kex991.htm), November 10, 2026
- [10-K (2025-12-31)](https://www.sec.gov/Archives/edgar/data/1899287/000189928726000015/0001899287-26-000015-index.htm), March 6, 2026
- [10-Q (2026-09-30)](https://www.sec.gov/Archives/edgar/data/1899287/000189928726000071/0001899287-26-000071-index.htm), November 12, 2026

Clearthesis research is for information and education only. It is not investment advice.
